← Eichor
Condition: Liver Fibrosis Nash Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Liver Fibrosis Nash

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Liver Damage and Cardiometabolic Disorders in NAFLD
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04036357Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05623150Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
Phase 2 · 1 location(s) · VA Office of Research and Development · NCT05526144Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NA · 2 location(s) · Pichamol Jirapinyo, MD, MPH · NCT06138821Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
NA · 3 location(s) · E-Scopics · NCT06661655The European NAFLD Registry
Phase N/A · 37 location(s) · Newcastle University · NCT04442334Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease
Phase N/A · 2 location(s) · Brigham and Women's Hospital · NCT05728697Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
Phase 4 · 1 location(s) · Getz Pharma · NCT05644717Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT05330923PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT04371042Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
Phase N/A · 1 location(s) · German Diabetes Center · NCT05046483InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796Integrated Diagnostics for Early Diagnosis of Liver Disease
Phase N/A · 1 location(s) · Manchester University NHS Foundation Trust · NCT04666402Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme
Phase N/A · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT07658755Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
NA · 1 location(s) · Université de Sherbrooke · NCT06843148Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
Phase 2 · 1 location(s) · Hudson Biotech · NCT07481734An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease
NA · 2 location(s) · Khyber Medical University Peshawar · NCT07294963A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Phase 3 · 361 location(s) · 89bio, Inc. · NCT06318169Digoxin In NASH (CODIN)
Phase 2 · 2 location(s) · Yale University · NCT06588699Identification of Liver Fibrosis Biomarkers
Phase N/A · 2 location(s) · Roche Diagnostics GmbH · NCT06819917Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
NA · 13 location(s) · University Hospital, Angers · NCT05699018Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD
NA · 20 location(s) · University Hospital, Angers · NCT04681573Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
NA · 1 location(s) · Maja Thiele · NCT03308916Biomarkers in the Diagnosis and Prognosis of NAFLD
Phase N/A · 1 location(s) · University of Trieste · NCT06098417Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Phase N/A · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07265544
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.